Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osama Dasa

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Trends in Cardiovascular Medicine|June 6, 2022
Editorial commentary: Resting heart rate and outcomes: Risk marker or risk factor?Osama Dasa, Mohammed Ruzieh
Lancet (London, England)|February 10, 2020
Polypill for prevention of cardiovascular diseasesOsama Dasa, Mohammed Ruzieh
The American Journal of Medicine|September 17, 2020
Sex Differences, Aspirin, and Primary PreventionOsama Dasa, Carl J Pepine
The New England Journal of Medicine|September 8, 2021
Somatic Mutations in "Benign" DiseaseOsama Dasa, Thomas A Pearson
American Journal of Therapeutics|April 2, 2015
Successful Treatment of Life-Threatening Interstitial Lung Disease Secondary to Antisynthetase Syndrome Using Rituximab: A Case Report and Review of the LiteratureOsama Dasa, Mohammed Ruzieh, Omar Oraibi
Gastroenterology|April 15, 2019
Gas in the LiverOsama Dasa, Morgan K Moroi, Mohammed Ruzieh
International Journal of Cardiology|November 28, 2022
An international perspective on low-dose aspirin for the primary prevention of myocardial infarctionOsama Dasa, Carl J Pepine, Thomas A Pearson
Case Reports in Pulmonology|August 16, 2016
Endobronchial Cartilage Rupture: A Rare Cause of Lobar CollapseOsama Dasa, Nauman Siddiqui, Mohammed Ruzieh, et al.
American Journal of Therapeutics|August 31, 2016
Intravenous Tissue Plasminogen Activator as Provocateur of Myocardial InfarctionJordan Burlen, Liza Cholin, Mohammed Ruzieh, et al.
The American Journal of Cardiology|November 22, 2020
Aspirin in Primary Prevention: What Changed? A Critical Appraisal of Current EvidenceOsama Dasa, Carl J Pepine, Thomas A Pearson
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Trends in Cardiovascular Medicine|June 6, 2022
Editorial commentary: Resting heart rate and outcomes: Risk marker or risk factor?Osama Dasa, Mohammed Ruzieh
Lancet (London, England)|February 10, 2020
Polypill for prevention of cardiovascular diseasesOsama Dasa, Mohammed Ruzieh
The American Journal of Medicine|September 17, 2020
Sex Differences, Aspirin, and Primary PreventionOsama Dasa, Carl J Pepine
The New England Journal of Medicine|September 8, 2021
Somatic Mutations in "Benign" DiseaseOsama Dasa, Thomas A Pearson
American Journal of Therapeutics|April 2, 2015
Successful Treatment of Life-Threatening Interstitial Lung Disease Secondary to Antisynthetase Syndrome Using Rituximab: A Case Report and Review of the LiteratureOsama Dasa, Mohammed Ruzieh, Omar Oraibi
Gastroenterology|April 15, 2019
Gas in the LiverOsama Dasa, Morgan K Moroi, Mohammed Ruzieh
International Journal of Cardiology|November 28, 2022
An international perspective on low-dose aspirin for the primary prevention of myocardial infarctionOsama Dasa, Carl J Pepine, Thomas A Pearson
Case Reports in Pulmonology|August 16, 2016
Endobronchial Cartilage Rupture: A Rare Cause of Lobar CollapseOsama Dasa, Nauman Siddiqui, Mohammed Ruzieh, et al.
American Journal of Therapeutics|August 31, 2016
Intravenous Tissue Plasminogen Activator as Provocateur of Myocardial InfarctionJordan Burlen, Liza Cholin, Mohammed Ruzieh, et al.
The American Journal of Cardiology|November 22, 2020
Aspirin in Primary Prevention: What Changed? A Critical Appraisal of Current EvidenceOsama Dasa, Carl J Pepine, Thomas A Pearson
Pageof 5